Shandong Xinhua Pharmaceutical Company Limited (XIN) — Cash Flow Reinvestment Rate

Latest as of September 2023: 2.64x

Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Cash Flow Reinvestment Rate of 2.64x as of September 2023, reinvesting €148.38 Million (capex €80.69 Million plus investments €-67.69 Million) from operating cash flow of €56.11 Million. Explore XIN capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.64x
(Capex + Investments) / Operating CF

Total Reinvested

€148.38 Million
Capex + Investments

Operating Cash Flow

€56.11 Million
EUR

Capital Expenditures

€80.69 Million
EUR

Shandong Xinhua Pharmaceutical Company Limited Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Also explore Shandong Xinhua Pharmaceutical Company L (XIN) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)

Year-by-year capital reinvestment analysis for Shandong Xinhua Pharmaceutical Company Limited. For live market cap and broader valuation context, see market value of Shandong Xinhua Pharmaceutical Company L.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.23x €125.40 Million €533.73 Million €115.60 Million ▼ -60.8%
2024 0.60x €220.60 Million €367.61 Million €212.42 Million ▼ -74.7%
2023 2.38x €630.24 Million €265.28 Million €325.13 Million ▲ +280.3%
2022 0.62x €473.66 Million €758.24 Million €244.76 Million ▼ -66.8%
2021 1.88x €486.92 Million €259.12 Million €249.23 Million ▲ +154.6%
2020 0.74x €310.19 Million €420.19 Million €280.19 Million ▼ -39.3%
2019 1.22x €423.28 Million €348.27 Million €366.51 Million ▼ -11.6%
2018 1.37x €445.21 Million €323.91 Million €388.44 Million ▲ +82.1%
2017 0.75x €294.31 Million €389.97 Million €261.11 Million ▼ -29.5%
2016 1.07x €470.36 Million €439.35 Million €227.07 Million ▲ +97.0%
2015 0.54x €189.42 Million €348.64 Million €169.09 Million ▼ -32.4%
2014 0.80x €278.23 Million €346.34 Million €260.17 Million ▼ -76.7%
2013 3.45x €362.58 Million €104.99 Million €344.53 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow